Financial Highlights – Q2FY27 (Consolidated)

  • Revenue from Operations: ₹2,307 crore, an increase of 10.4% Year-over-Year (YoY).
  • Earnings Before Interest, Tax, Depreciation, and Amortization (EBITDA): ₹174 crore.
  • Profit Before Tax (PBT) before exceptional items^: ₹130 crore.
  • Profit After Tax (PAT): ₹104 crore.
  • *Earnings Per Share (EPS):** ₹10.84 (not annualized).

Financial Highlights – H1FY27 (Consolidated)

  • Revenue from Operations: ₹4,589 crore.
  • Earnings Before Interest, Tax, Depreciation, and Amortization (EBITDA): ₹366 crore.
  • Profit Before Tax (PBT) before exceptional items^: ₹279 crore.
  • Profit After Tax (PAT): ₹218 crore, which includes an exceptional gain.
  • Exceptional Gain: ₹32.19 crore, comprising ₹23.02 crore from the sale of the MedTech business and ₹9.17 crore as profit on the sale of a property.
  • *Earnings Per Share (EPS):** ₹22.75 (not annualized).

Segment-Wise Performance Overview – Q2FY27

Segment 1: Electro-Mechanical Projects and Commercial Air Conditioning Systems

  • The product business within this segment delivered robust revenue growth.
  • The project business revenue remained subdued due to execution delays.
  • Segment margins were under pressure as material cost escalations could not be fully passed on to customers.
  • Supplies of US heat pumps continued, despite facing supply chain and logistics challenges, and are seeing growing market acceptance.
  • Order enquiry levels remain strong, with significant growth in order inflows expected.

Segment 2: Unitary Products

  • Strong demand for Room Air Conditioners was supported by an extended summer.
  • Margins remained under pressure; only a part of the material cost escalation could be passed on despite periodic price increases.
  • The Commercial Refrigeration business began to see a revival in demand for key product categories like Deep Freezers, Bottled Water Dispensers, and Storage Water Coolers.

Segment 3: Professional Equipment & Industrial Solutions

  • The sale of the company's MedTech business was completed on August 31, 2026.
  • Margins for this segment improved due to a write-back of warranty provisions, following the cessation of obligations related to the divested MedTech products.
  • The Industrial Solutions business continued its steady growth, supported by demand from the manufacturing and testing sectors.

Balance Sheet Position – H1FY27

A balance sheet summary was presented for the half-year ended September 30, 2026, though specific figures were not detailed in the provided text.

ESG (Environmental, Social, and Governance) Practices

  • Environment: Focus on energy-efficient products (green refrigerants, inverter compressors), reusable packaging, and green infrastructure (IGBC-certified offices/plants, Net Zero Energy Platinum office). Sustainable manufacturing initiatives include a 6 MWp solar system supplying ~15% of energy, with a 1.2 MWp captive system under commissioning. Practices also include circular economy efforts like e-waste compliance and product refurbishment.
  • Social: The company reports 16.67% female representation on the Board and 11.66% among permanent employees. CSR initiatives include skill development (500+ youth, 375 apprentices), education and health support for thousands of students, and women empowerment programs (vocational training for 500+ women).
  • Governance: The board has a balanced representation of Executive and Non-Executive Directors. The company maintains a robust compliance framework including a Code of Conduct, Whistle Blower Policy, and an Integrated Governance, Risk & Compliance (GRC) policy based on COSO 2017.

Forward Looking Statement

The presentation contains standard forward-looking statements regarding future operations and financial performance, dependent on assumptions and subject to various risks and uncertainties.